Jay Young, MD
Colon & Rectal Surgery · Knoxville, TNNPI 1396826368
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 68.1% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2020 at $3,586 and has fallen 98.2% since, to $64 in 2025.
Across 102 payments — averaging $47.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Takeda Pharmaceuticals U.S.A., Inc.$262
- Stryker$224
- Medtronic$96
- La Jolla Pharmaceutical Company$91
- Kowa Pharmaceuticals America, Inc.$91
- plus $787 from 22 others
What the payments were for
- Travel & lodging$3597%
- Food & beverage$2,00341%
- Education$2,50051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $3,310 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $262 |
| Stryker | 2 | $224 |
| Medtronic(2 entities) | 6 | $96 |
| La Jolla Pharmaceutical Company | 4 | $91 |
| Kowa Pharmaceuticals America, Inc. | 7 | $91 |
| Johnson & Johnson | 4 | $78 |
| Ferring Pharmaceuticals Inc. | 5 | $76 |
| Axonics, Inc. | 4 | $74 |
| Braintree Laboratories, Inc. | 5 | $71 |
| THD America, Inc. | 6 | $68 |
| Sanara Medtech Inc. | 4 | $62 |
| Zyla Life Sciences, Inc. | 4 | $53 |
| Covidien LP | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Baxter Healthcare | 2 | $23 |
| TELA Bio, Inc. | 1 | $23 |
| Ambu Inc. | 1 | $20 |
| Capsovision, Inc. | 1 | $18 |
| Abbott | 1 | $16 |
| Acell, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Merck | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Convatec Inc. | 1 | $13 |
| Triad Life Sciences Inc. | 1 | $13 |
| Coopersurgical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,862 in reported general payments places this provider in the 70th percentile of 31 colon & rectal surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 114 | $13,901 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 80 | $5,336 |
| Colestipol Hcl | 35 | $3,501 |
| Lubiprostone | 14 | $1,865 |
| CholestyramineCholestyramine (With Sugar) | 11 | $1,003 |
| Celecoxib | 83 | $716 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $608 |
| Sulfasalazine | 13 | $420 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $354 |
| Hydroxyzine Pamoate | 55 | $251 |
| Neomycin Sulfate | 46 | $250 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $237 |
| Metronidazole | 53 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 32 | $121 |
| Ondansetron Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Suflave | $71 | $13,901114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 31 colon & rectal surgery providers in Tennessee.
Other colon & rectal surgery in Knoxville
- Gregory LowKnoxville$6K
- Sung LeeKnoxville$1K
- Elissa FalconerKnoxville$1K
- James BakerKnoxville$638
- Christopher SmithKnoxville$206
- Aimal KhanNashville$35K
- Sree SuryadevaraNashville$24K
- Justin MonroeMemphis$14K
- William HarbNashville$8K
- Shannon McChesneyNashville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.